A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

from Feed: All Latest https://ift.tt/ZrfD9Oj
via IFTTT

No comments:

Post a Comment

You Can Finally Change the Snooze Duration in iOS 26

The iPhone’s Clock app is one of the slowest moving apps on iPhone. It gets less love and attention than even the Phone app. While there are...